Director Trades
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Alcidion.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: Neuren breakthrough, M&A deals, and why EBOS ticks ESG boxes
News
10 at 10: These ASX stocks are delivering some early Christmas cheer this morning
Health & Biotech
ASX Health Stocks: Alcidion wins Aussie government contract, while Resonance seeks US FDA nod
News
10 at 10: These ASX stocks are leaving investors satisfied this morning
Health & Biotech
ASX Health Stocks: Proteomics jumps 13pc on diabetes test
News
Market Highlights and 5 ASX Small Caps to watch on Monday
News
ASX Small Cap Lunch Wrap: Who’s got something to cheer about this morning?
News
Quarterlies Top 5: Who said COVID-19 induced booms in seafood, tech and furniture were over?
News
Closing Bell: Today’s biggest small cap winners on the ASX
News
Market highlights and 5 ASX small caps to watch on Wednesday
Experts
ScoPo’s powerplays: ‘It’s going to be a great run into 2021’
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s dreaming of the Pacific today?
Health & Biotech
Alicidion lands bumper contract as the UK’s NHS goes digital
News
10 at 10: These ASX stocks are on the hunt this morning
News
Two small cap fund managers discuss their 2020 outlook, after a wild ride through the COVID-19 chaos
Health & Biotech